CTIS2023-507874-42-00进行中（未招募）1 期
A phase 2 trial assessing Ifenprodil as a ReMyelinating repurpOsed Drug in Multiple Sclerosis – MODIF-MS
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 80
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 64（—）
- 性别
- All
入选标准
- 未提供
排除标准
- 未提供
研究者
相似试验
已完成
不适用
The prospective study of effect of ifenprodil on relapse prevention in patients with substance dependenceAlcohol dependenceJPRN-UMIN000006347Tokyo Metropolitan Institute of Medical Science100
已完成
不适用
A Phase II Study of Eribulin Evaluating Efficacy and Safety as first or secondary line chemotherapy for advanced or metastatic breast cancer without HER2 overexpressingAdvanced or metastatic breast cancerJPRN-UMIN000009568General and Gastroenterological Surgery, Osaka Medical College35
尚未招募
1 期
A study combining blood pressure medication with standard treatment in advanced melanoma. ACE-IT-001Melanoma - UnresectableMelanoma - MetastaticCancer - Malignant melanomaACTRN12621000156886Calvary Mater Newcastle30
进行中（未招募）
1 期
A Study of LY2784544 in patients with blood cancerEUCTR2011-001012-56-DEEli Lilly and Company121
进行中（未招募）
1 期
A Study of LY2784544 in patients with blood cancerEUCTR2011-001012-56-ATEli Lilly and Company188